JSPR – jasper therapeutics, inc. - class a (US:NASDAQ)
Stock Stats
News
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $65.00 price target on the stock.
Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $70.00 price target on the stock.
Jasper Therapeutics (JSPR) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference [Yahoo! Finance]
Form ARS Jasper Therapeutics, For: Dec 31
Form DEFA14A Jasper Therapeutics,
Form DEF 14A Jasper Therapeutics, For: Jun 06
Form SC 13G Jasper Therapeutics, Filed by: Avidity Partners Management LP
Form 4 Jasper Therapeutics, For: Mar 12 Filed by: Mahal Jeetinder Singh
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.